Aarti Pharmalabs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Pharmalabs Limited has notified the stock exchange that its trading window has been closed in line with SEBI's Prohibition of Insider Trading Regulations, 2015. During this period, designated insiders such as directors, key managerial personnel, and connected persons are prohibited from trading in the company's shares. This is a routine compliance measure typically enforced ahead of key corporate announcements, most often quarterly or annual financial results.
This is a standard regulatory filing with no direct impact on retail shareholders or stock price. It simply indicates that upcoming financial results or a material announcement may be expected soon.